Search research articles
Contact Us
Filters
Showing results (261-270 of 604) with videos related to
Page
of 61
Sort By:
Nature
|
January 15, 2020
Publisher Correction: Dietary salt promotes cognitive impairment through tau phosphorylation
Giuseppe Faraco, Karin Hochrainer, Steven G Segarra, et al.
The Journal of Clinical Investigation
|
June 6, 2023
APOE-ε4 synergizes with sleep disruption to accelerate Aβ deposition and Aβ-associated tau seeding and spreading
Chanung Wang, Aishwarya Nambiar, Michael R Strickland, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 14, 2011
Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-β amyloidosis
Jungsu Kim, Hong Jiang, Seonha Park, et al.
Human Molecular Genetics
|
October 18, 2017
Behavioral and transcriptomic analysis of Trem2-null mice: not all knockout mice are created equal
Silvia S Kang, Aishe Kurti, Kelsey E Baker, et al.
JAMA Neurology
|
March 13, 2013
Sleep quality and preclinical Alzheimer disease
Yo-El S Ju, Jennifer S McLeland, Cristina D Toedebusch, et al.
Nature Neuroscience
|
June 19, 2024
Apolipoprotein E in Alzheimer's disease trajectories and the next-generation clinical care pathway
Sneha Narasimhan, David M Holtzman, Liana G Apostolova, et al.
Journal of Alzheimer'S Disease : JAD
|
April 23, 2016
Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease
Adam P Ingber, Jason Hassenstab, Anne M Fagan, et al.
Plos One
|
March 5, 2015
Cerebrospinal fluid levels of amyloid precursor protein are associated with ventricular size in post-hemorrhagic hydrocephalus of prematurity
Diego M Morales, Richard Holubkov, Terri E Inder, et al.
Neurobiology of Aging
|
February 25, 2015
Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer's disease biomarkers
Brian A Gordon, Jeffrey M Zacks, Tyler Blazey, et al.
Archives of Neurology
|
May 11, 2011
Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology
Anne M Fagan, Leslie M Shaw, Chengjie Xiong, et al.
Page
of 61
Search research articles
Search
Showing results (261-270 of 604) with videos related to
Sort By:
Page
of 61
Nature
|
January 15, 2020
Publisher Correction: Dietary salt promotes cognitive impairment through tau phosphorylation
Giuseppe Faraco, Karin Hochrainer, Steven G Segarra, et al.
The Journal of Clinical Investigation
|
June 6, 2023
APOE-ε4 synergizes with sleep disruption to accelerate Aβ deposition and Aβ-associated tau seeding and spreading
Chanung Wang, Aishwarya Nambiar, Michael R Strickland, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 14, 2011
Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-β amyloidosis
Jungsu Kim, Hong Jiang, Seonha Park, et al.
Human Molecular Genetics
|
October 18, 2017
Behavioral and transcriptomic analysis of Trem2-null mice: not all knockout mice are created equal
Silvia S Kang, Aishe Kurti, Kelsey E Baker, et al.
JAMA Neurology
|
March 13, 2013
Sleep quality and preclinical Alzheimer disease
Yo-El S Ju, Jennifer S McLeland, Cristina D Toedebusch, et al.
Nature Neuroscience
|
June 19, 2024
Apolipoprotein E in Alzheimer's disease trajectories and the next-generation clinical care pathway
Sneha Narasimhan, David M Holtzman, Liana G Apostolova, et al.
Journal of Alzheimer'S Disease : JAD
|
April 23, 2016
Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease
Adam P Ingber, Jason Hassenstab, Anne M Fagan, et al.
Plos One
|
March 5, 2015
Cerebrospinal fluid levels of amyloid precursor protein are associated with ventricular size in post-hemorrhagic hydrocephalus of prematurity
Diego M Morales, Richard Holubkov, Terri E Inder, et al.
Neurobiology of Aging
|
February 25, 2015
Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer's disease biomarkers
Brian A Gordon, Jeffrey M Zacks, Tyler Blazey, et al.
Archives of Neurology
|
May 11, 2011
Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology
Anne M Fagan, Leslie M Shaw, Chengjie Xiong, et al.
Page
of 61